137 related articles for article (PubMed ID: 223590)
1. Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Tsujita Y; Kuroda M; Tanzawa K; Kitano N; Endo A
Atherosclerosis; 1979 Mar; 32(3):307-13. PubMed ID: 223590
[TBL] [Abstract][Full Text] [Related]
2. Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Kuroda M; Tsujita Y; Tanzawa K; Endo A
Lipids; 1979 Jun; 14(6):585-9. PubMed ID: 110993
[TBL] [Abstract][Full Text] [Related]
3. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
N Engl J Med; 1981 Aug; 305(9):478-82. PubMed ID: 7254297
[TBL] [Abstract][Full Text] [Related]
4. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species.
Tsujita Y; Kuroda M; Shimada Y; Tanzawa K; Arai M; Kaneko I; Tanaka M; Masuda H; Tarumi C; Watanabe Y
Biochim Biophys Acta; 1986 Jun; 877(1):50-60. PubMed ID: 3636158
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
6. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals.
Endo A; Tsujita Y; Kuroda M; Tanzawa K
Biochim Biophys Acta; 1979 Nov; 575(2):266-76. PubMed ID: 508786
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
Tobert JA; Bell GD; Birtwell J; James I; Kukovetz WR; Pryor JS; Buntinx A; Holmes IB; Chao YS; Bolognese JA
J Clin Invest; 1982 Apr; 69(4):913-9. PubMed ID: 6918402
[TBL] [Abstract][Full Text] [Related]
8. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
9. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters.
Trautwein EA; Forgbert K; Rieckhoff D; Erbersdobler HF
Biochim Biophys Acta; 1999 Jan; 1437(1):1-12. PubMed ID: 9931405
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T
Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
[TBL] [Abstract][Full Text] [Related]
11. The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs.
Romero AL; West KL; Zern T; Fernandez ML
J Nutr; 2002 Jun; 132(6):1194-8. PubMed ID: 12042433
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
14. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Fears R; Richards DH; Ferres H
Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
[TBL] [Abstract][Full Text] [Related]
15. Effect of ML-236B (compactin) on biliary excretion of bile salts and lipids, and on bile flow, in the rat.
Kempen HJ; De Lange J; Vos-Van Holstein MP; Van Wachem P; Havinga R; Vonk RJ
Biochim Biophys Acta; 1984 Jul; 794(3):435-43. PubMed ID: 6743675
[TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
18. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
20. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
